|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
It's now July!
Have you registered yet?
Hear cutting edge presentations
Click here to view the program.
Take advantage of networking with your peers
Learn the latest in legislative/regulatory actions
Speak with the latest in vendor support
Enjoy the magnificent Boca Raton Resort!
Click here to register.
Florida pathologists call to action
Our Florida medicare service provider, First Coast Service Options, has a
draft local coverage determination submitted for public comment by July
27, 2015. This dLCD essentially mirrors the restrictive Palmetto LCD that
was approved earlier for that service area. This broad dLCD covers a wide
range of pathology anatomic services including breast, GI, GU, lung and
skin. Your FSP has been actively interacting with FCSO and with the CAP and is
requesting changes to this dLCD.
Better clinical devices are dependent on lab research
Instruments for electrophysiology research are designed to measure the electrical properties of biological cells and tissues. They record voltage change or electric current on a variety of scales, from single ion channel proteins to entire organs. Researchers use these instruments in many ways, for example, to understand the molecular events that control excitation in cardiac muscle. Ultimately, such research could provide a clearer understanding of the cellular basis of cardiac arrhythmias and their mechanisms.
Wearable health-monitoring devices could alter traditional role of pathologists as gatekeepers of medical laboratory test data
Traditionally, medical laboratories have been the gatekeepers for the lab test data of most patients. After all, it is regularly said that 70 percent or more of a patient's permanent health record is made up of clinical laboratory test data. However, several market forces are at play that could eat away at the long-standing role of medical laboratories as the primary gatekeepers of patient test data.
Gap remains with patient-physician online communication
Health Data Management
A national online survey of more than 2,200 CVS retail pharmacy customers finds that patients want to leverage email, Facebook and physician websites to communicate with their doctors. However, there remains a gap between patient interest for online communication and what physicians currently provide. The survey results, published in the Journal of General Internal Medicine, reveal that patients are interested in using Web-based tools to fill prescriptions, track their own health and access health information (37-57 percent), yet few are currently doing so (4-8 percent).
Editing stem cell genes will 'revolutionize' biomedical research
Applying a dramatically improved method for "editing" genes to human stem cells, University of Wisconsin-Madison professor of neuroscience Su-Chun Zhang has shown a new way to silence genes in stem cells and their progeny at any stage of development. The advance has advantages in speed and efficiency, says Zhang, and is already being used for basic biological studies.
Lab-made blood to enter human trials in 2 years
Medical News Today
Artificial blood grown in a lab from stem cells is one step closer to being available to people with complex blood types for whom it is difficult to find matching donors. The U.K.'s NHS (National Health Service) Blood and Transplant say manufactured blood will be used in clinical trials with human volunteers within 2 years. The aim is one of several that the joint England and Wales special health authority has entered into with top universities to develop transfusion, transplantation and regenerative medicine over the next 5 years.
Miss an issue of Pathology Today? Click here to visit the Pathology Today archive page.
UC San Diego sues USC and scientist, alleging conspiracy to take funding, data
Los Angeles Times
UC San Diego has sued USC and a nationally recognized Alzheimer's disease researcher, alleging that they illegally conspired to take federal funding, data and employees from a UC San Diego study center on the illness. UC San Diego has sued USC and a nationally recognized Alzheimer's disease researcher, alleging that they illegally conspired to take federal funding, data and employees from a UC San Diego study center on the illness.
UVA Health System opens high-tech clinical genomics lab
The University of Virginia Health System has opened a high-tech clinical genomics lab that will personalize care for patients, help doctors determine the best treatments for cancers and other diseases, and allow UVA to offer the most cutting-edge clinical trials. The new lab, under the direction of Mani S. Mahadevan, M.D., professor in the Department of Pathology, gives doctors the power to examine patients' DNA quickly and effectively. By so doing, they can diagnose genetic disorders, identify cancer-causing gene mutations and tailor treatments for maximum effectiveness.
6 laboratory tasks supplanted by automation
Genetic Engineering & Biotechnology News
The global market for lab automation is set to grow over the next five years into a $5.106 billion industry by 2020, MarketsandMarkets projected recently, based on a 2014 figure of $3.474 billion and projected compound annual growth rate of 6.7 percent from this year. However, Kalorama is more even upbeat. They reported total sales of $5.4 billion in lab automation systems sold to clinical labs alone in 2014.
Disclaimer: The authors, editors, and the Florida Society of Pathologists (FSP) Executive Committee affiliated with "Florida Pathology Today" e-Newsletter cannot and do not warrant the completeness, accuracy, non-infringement, merchantability, timeliness or fitness for a particular purpose of the information or views contained within this publication, or available through the links provided within articles contained within this publication.
FSP has no control over and does not officially endorse the content of the information available on the links contained in the "Florida Pathology Today" or links imbedded in articles within the "Florida Pathology Today." These links are provided as a courtesy only. Linked sites are not a part of the "Florida Pathology Today." The owners of those linked sites, and not FSP, own the intellectual property rights to the material on the linked sites. FSP cannot certify the accuracy of material published on linked sites. Additionally, the contents of this e-Newsletter and the above referenced links, including any advice, suggestions, and/or recommendations have NOT been generated as part of any professional evaluation.
The authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" e-Newsletter shall not be liable to anyone for any loss or injury caused in whole or in part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting or delivering this e-Newsletter and any information included in this e-Newsletter.
Under no circumstances will the authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" be liable to you or anyone else for any decision made or any action taken by you or anyone else in reliance on such information or view, or for any incidental, consequential, special, or similar damages even if advised of the possibility of such damages.
The above warranties are the only warranties of any kind either expressed or implied, including warranties of merchantability or fitness for any particular purpose.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063